Biotechnology in Japan

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Astellas Pharma Inc.

Daiichi Sankyo Co., Ltd.

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Company Limited

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

Table 1: Japan biotechnology industry value: $ billion, 2012-16

Table 2: Japan biotechnology industry category segmentation: $ billion, 2016

Table 3: Japan biotechnology industry geography segmentation: $ billion, 2016

Table 4: Japan biotechnology industry value forecast: $ billion, 2016-21

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials ($)

Table 7: Astellas Pharma Inc.: key financials (¥)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: Daiichi Sankyo Co., Ltd.: key facts

Table 10: Daiichi Sankyo Co., Ltd.: key financials ($)

Table 11: Daiichi Sankyo Co., Ltd.: key financials (¥)

Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios

Table 13: Mitsubishi Tanabe Pharma Corporation: key facts

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($)

Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (¥)

Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios

Table 17: Takeda Pharmaceutical Company Limited: key facts

Table 18: Takeda Pharmaceutical Company Limited: key financials ($)

Table 19: Takeda Pharmaceutical Company Limited: key financials (¥)

Table 20: Takeda Pharmaceutical Company Limited: key financial ratios

Table 21: Japan size of population (million), 2012-16

Table 22: Japan gdp (constant 2005 prices, $ billion), 2012-16

Table 23: Japan gdp (current prices, $ billion), 2012-16

Table 24: Japan inflation, 2012-16

Table 25: Japan consumer price index (absolute), 2012-16

Table 26: Japan exchange rate, 2012-16

List of Figures

Figure 1: Japan biotechnology industry value: $ billion, 2012-16

Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2016

Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2016

Figure 4: Japan biotechnology industry value forecast: $ billion, 2016-21

Figure 5: Forces driving competition in the biotechnology industry in Japan, 2016

Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2016

Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2016

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2016

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2016

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2016

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: Daiichi Sankyo Co., Ltd.: revenues & profitability

Figure 14: Daiichi Sankyo Co., Ltd.: assets & liabilities

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities

Biotechnology in Japan

Summary

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.Synopsis

Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.Key Highlights

• The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
• The Japanese biotechnology industry had total revenues of $35.8bn in 2016, representing a compound annual growth rate (CAGR) of 3% between 2012 and 2016.
• The environment and industrial processing segment was the industry's most lucrative in 2016, with total revenues of $13.9bn, equivalent to 38.9% of the industry's overall value.
• With the increasing targets for reducing Japan’s carbon footprint, there is a growing requirement for the environment and industrial processing segment.

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

• What was the size of the Japan biotechnology market by value in 2016?
• What will be the size of the Japan biotechnology market in 2021?
• What factors are affecting the strength of competition in the Japan biotechnology market?
• How has the market performed over the last five years?
• What are the main segments that make up Japan's biotechnology market?